肝癌肝移植

肝移植和肝切除是目前肝癌的2种主要治疗方法。早期肝癌合并晚期肝病患者肝移植后疗效评估最佳；但是对于肝功能代偿尚可、不伴门静脉高压的早期肝癌患者来说，最佳的治疗方案仍存在争议。大量的研究证明肝移植后无病生存率更高，但是尚不清楚长期生存率如何。通过改进手术技术和实行补救性肝移植的方法可明显改善肝切除后患者生存率，且避免了可因切除治愈的患者因等待移植时间过长而失去机会。

Liver transplantation for hepatocellular carcinoma

Liver transplantation and hepatic resection remain the standard curative therapies for hepatocellular carcinoma （HCC）.Currently,patients with early-stage HCC and advanced liver disease are best served by transplant evaluation.However,the best treatment strategy for patients with well-preserved liver function,absence of portal hypertension,and early-stage HCC is debated.Numerous studies have documented better disease-free survival with transplantation,although the benefit on overall survival is less clear.By improving the surgical technique and practicing the method of salvage liver transplantation can significantly improve survival rate after liver resection,and avoid the patients who can be cured by resection dropping out the list due to the long waiting time.